Abstract Staphylococcus aureus bacteraemia (SAB) is an important cause of community and nosocomial sepsis, with a significant mortality rate. Infective endocarditis (IE) is a serious complication, occurring in up to 25 % of cases. Transoesophageal echocardiography (TOE) significantly improves the sensitivity of diagnosis. We compared the sensitivity and specificity of clinical evaluation alone in diagnosing IE. We evaluated all adult patients with SAB at our centre from 1998 to 2006 in order to determine what proportion of clinically unsuspected cases were diagnosed with IE on TOE. IE was defined according to modified Duke criteria. The median age of the patients was 68 years, 77 % were male and the majority of cases did not have a known pre-existing condition. Twenty-one percent were methicillin-resistant Staphylococcus aureus (MRSA). Intravascular device was the most common cause of bacteraemia. TOE was performed in 144 (100 %) of the cases. IE was suspected clinically in 15 % of cases, and the overall prevalence of possible or definite IE on TOE-inclusive Duke criteria was 29 % (n=41). Following TOE, 22 (15 %) cases were reclassified as either possible or definite endocarditis. TOE detected a vegetation in 37 (90 %) of the 41 cases of IE. Nineteen (46 %) were not suspected clinically by Duke criteria. Sensitivity improved in the presence of pre-existing valve lesion or community acquisition. The overall inhospital mortality was 10 %. There is a high incidence of endocarditis in SAB and a large percentage of cases are not evident on clinical grounds. TOE evaluation is indicated for all medically suitable adult patients with SAB in order to improve the detection of endocarditis.
Introduction
Staphylococcus aureus bacteraemia (SAB) is an important cause of community and health care-associated sepsis, with a significant mortality rate [1] [2] [3] . Infective endocarditis (IE) is a serious complication, occurring in up to 25 % of cases [4] [5] [6] [7] . Important risk groups include injecting drug users, the elderly, those with intravascular prostheses and haemodialysis patients [8, 9] . An early diagnosis is essential for the appropriate duration of antimicrobial therapy and is often extended to 6 weeks. The mortality of Staphylococcus aureus IE can be as high as 50 % [4, 5] . Transoesophageal echocardiography (TOE) significantly improves the sensitivity of diagnosis, but may not be readily available in many centres [6, 7, 10, 11] . Some investigators advocate routine transthoracic echocardiography alone in cases of uncomplicated SAB with a clearly defined source [8, 12] . We reviewed our experience at a referral centre where TOE is performed routinely in all adult patients with SAB. We compared the sensitivity and specificity of clinical evaluation including transthoracic echocardiography alone in diagnosing IE.
Methods and definitions
All cases of SAB were identified from the microbiology laboratory of Barwon Health during the study period. Patients were excluded if they were younger than 18 years of age, managed at another centre or had refused TOE. We prospectively enrolled all adult patients with SAB at our centre from 1998 to 2006 to assess the sensitivity and specificity of clinical versus TOE-inclusive criteria to determine what proportion of clinically unsuspected cases were only diagnosed on TOE. The Barwon Health Research and Ethics committee approved this project and all patients provided written informed consent for TOE. Using a twoby-two table analysis, the sensitivity, specificity, negative and positive predictive values, and likelihood ratios of clinical evaluation alone was estimated.
Patient characteristics, known risk factors and in-hospital outcomes were also analysed. Predisposing factors included injecting drug use or valvular condition (i.e. prosthetic valve or a valve lesion with significant regurgitation or turbulence of blood flow), presence of diabetes mellitus, immunosuppression or haemodialysis. Health care-associated SAB was defined as a new positive blood culture more than 48 h after admission to hospital. SAB occurring within 48 h of admission was considered to be community associated.
Clinically suspected IE was defined according to modified Duke Criteria as per Li et al. [13] , including possible, definite and excluded, in the absence of TOE findings. See Table 1 .
The presence of predisposing cardiac valve lesions was not always apparent at admission. In addition, at our centre, all cases of SAB are referred to the Infectious Diseases Service promptly and undergo a thorough clinical assessment by senior clinicians. Briefly, key clinical findings suggesting possible IE included the presence of a new regurgitant cardiac murmur, cardiac failure, evidence of metastatic infection or any vascular embolic phenomena, and all patients underwent inhospital transthoracic echocardiography.
We evaluated several in-hospital outcomes, including the need for cardiac surgery, 30-day mortality, any metastatic complications, clinical cure or resolution of infection. Metastatic complications included embolic stroke, bone or joint infection, and septic pulmonary emboli. Clinical cure was defined as complete recovery at 3 months follow up with normal inflammatory markers. The resolution of infection during in-hospital admission was defined as resolution of fever, clearance of blood cultures and improving inflammatory markers. Relapsed infection was defined as increased inflammatory markers and/or positive cultures despite appropriate initial therapy. All patients were followed to at least 3 months by the Infectious Diseases Service.
Results

Demographic and pre-existing lesions
During the study period from 1998 to 2006, we identified a total of 230 episodes of SAB from our microbiology laboratory managed at our centre. Following exclusion for age less than 18 years (55) or patients who had refused TOE (31), we included a total of 144 (83 %) adult cases for this study. TOE was performed between 3 and 7 days in all cases.
The median age of the cohort was 68 years, and male patients represented 77 % of the study population. In terms of known risk factors for IE, the majority of cases did not have a known pre-existing condition (n= 81, 57 %). Diabetes mellitus comprised 19 % of cases, followed by haemodialysis patients (12.5 %) and immunosuppressed patients (combined corticosteroids and other immunosuppression use, 8.3 %). Eighty percent of patients did not have a pre-existing valvular heart condition and only nine patients had a prosthetic valve. Methicillin-susceptible Staphylococcus aureus (MSSA) was present in 79 % of cases and methicillin resistance Table 1 Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis (IE). Adapted from Li et al. [13] Duke criteria on clinical grounds: Definite endocarditis: any one of the following: (MRSA) in 21 %. There was a single case of communityacquired MRSA (CA-MRSA). Health care-associated bacteraemia was more common than community-acquired bacteraemia (56 % vs. 44 %), and, of these, MRSA represented 31 % of cases. MRSA was more commonly acquired in the hospital setting than in the community (31 % vs. 7.8 %, respectively; p=0.001). Of the patients with IE, 58 % (24/41) had no clinical risk factors, and the frequencies of diabetes mellitus, immunosuppression and haemodialysis were 7.3, 7.3 and 2.4 %, respectively. See Table 2 .
Source of infection
Intravascular catheter devices were the most common cause of bacteraemia. Central and peripheral intravascular catheters were the primary clinical sources of infection in 37 % of cases (n=54). This was followed by skin infection (cellulitis, wound or ulcer), contributing a further 27 % of cases. See Table 3 .
Results of TOE TOE was successfully completed in 144 (100 %) of the cases. IE was suspected clinically in 15 % of cases (n= 22); however, the overall prevalence of IE as defined by the gold standard of either possible or definite on TOEinclusive Duke criteria was 29 % (n=41).
Of the 144 patients, 122 cases were thought not to have IE prior to TOE. Following TOE, 22 (15 %) cases were reclassified as either possible IE (n=6), where irregularities less than 2 mm or valve thickening was noted on TOE but not specific vegetations, or definite IE (n=16) on the basis of significant mobile vegetations larger than 1-2 mm detected that had not been identified on transthoracic echocardiography. The diagnosis of IE was rejected in 100 cases (72 %).
TOE detected a vegetation in 37 (90 %) of the 41 cases of IE and 19 (46 %) of the 41 cases were not suspected clinically by Duke criteria. The sensitivity and specificity of the clinical evaluation is shown in Table 4 . The sensitivity improved in the presence of known risk factors, such as pre-existing valve lesion or community acquisition.
At TOE, there were a total of 40 vegetations in 37 cases (26 %). Of these, 14 (38 %) involved the mitral valve, 12 (32 %) the aortic valve, 5 (14 %) were right-sided vegetations and 6 (16 %) were mixed valvular or device-related infections. See Table 5 .
Complications and outcome
The in-hospital clinical outcomes of all the cases of SAB were evaluated. Cardiac surgery was performed in two cases for IE and the overall in-hospital mortality<30 days was 10 % (14 cases). The important complications and outcomes are described in Table 6 . 
Discussion
We found that just over half the cases of IE were clinically unsuspected. Over a quarter of the patients had IE, of which only a half had suggestive signs. Although the sensitivity of a more general clinical rule (clinical suspicion or preexisting valve lesion or community onset) was higher, a significant minority of patients with none of these features had IE. Our other findings are consistent with other reported case series of endocarditis [6, 7] . In this single-centre study of an 8-year cohort of adult patients with SAB, we found that the epidemiology reflects that reported in the literature with increased age and male predominance [1, 4, 5] . Most cases did not have known underlying risk factors such as preexisting cardiac lesions; however, diabetes mellitus, haemodialysis and immunosuppression were common and have been noted in other SAB studies [1, 3, 8, 10] . A significant number of cases, 56 %, were health careassociated and 21 % were MRSA. Most of the health careassociated cases were related to an intravascular device source and this association been well reported in the literature and reflects the changing epidemiology of SAB and IE [1, 3, 4, 8, 13] . This finding underlines the importance of prevention through meticulous line care and early intravascular device removal.
We identified that a significant proportion of patients had IE, with an overall incidence of 29 % (41 of 144 patients). This has been reported in the literature but, importantly, in our study, 46 % (19 of 41) of cases were not suspected on clinical grounds [4] [5] [6] [7] . Kaasch et al. report an incidence rate of up to 9.3 % in their cohort study, but TOE was not performed in 43 % of cases [12] . TOE was safe and well tolerated and there were no adverse events reported in our cohort.
The sensitivity of clinical assessment alone improved in the presence of a pre-existing valvular heart lesion or a history of community acquisition from 46 to 73 %, respectively, but, overall, remained low. This provides some simple epidemiologic clues in ascertaining the risk of IE for patients with SAB. This contrasts with the findings of Kaasch et al., who reported a very high negative predictive value in health care-associated SAB using criteria such as persistent bacteraemia (>4 days) and the presence of an intracardiac device, among other clinical findings. However, significantly, this cohort study had a low utilization of TOE of only 43-60 % and in up to 50 % of cases of persistent bacteraemia, was not adequately defined [12] .
There remains significant debate in the scientific community regarding the need for detailed evaluation of all cases of SAB, particularly those which appear uncomplicated. For patients experiencing short-duration bacteraemia, a known removable source and no underlying cardiac lesions, a high-quality transthoracic echocardiography may be appropriate in limited settings. Increasingly, patients with SAB in modern health care rarely fulfill these criteria and will require a more detailed evaluation and careful monitoring [8, 9, 14] .
Outcomes in our cohort of SAB were similar to that reported in the literature, with an overall in-hospital mortality rate of 10 % [2, 3] . Interestingly, we found a relatively low rate of cardiac surgery in those cases confirmed with IE. Cardiac surgery has been reported in up to 40 % of cases, with left heart involvement in some series [8] . The relatively low rate of surgery may reflect earlier diagnosis and treatment or, perhaps, less severe disease in our patients [8] , but this requires further analysis.
Some important limitations of this study include a singlecentre experience with ready access to TOE. The diagnostic process including TOE was performed prospectively as the standard of care; however, the patient outcome data were analysed subsequent to the hospital admission and the medical decision making was obtained from the patient records. Given the well-reported reduced sensitivity, we chose not to make a direct comparison of the role of transthoracic echocardiography alone in patients with SAB [11, 15] . Although the objective of this study was to better define the role of TOE in diagnosing or excluding IE in patients with SAB, there is often a clinical indication for repeat studies, particularly if there is a poor clinical response or persistent bacteraemia [14] . We recommend that any implementation of this policy in different clinical contexts requires further evaluation.
Conclusion
There is a high incidence of infective endocarditis (IE) in Staphylococcus aureus bacteraemia (SAB) (29 %) and a large percentage of cases are not evident on clinical grounds. Following transoesophageal echocardiography (TOE), 22 (15 %) cases were reclassified as either possible (n=6) or definite endocarditis (n=16). TOE evaluation is indicated for all adult patients with SAB in order to improve the detection of endocarditis.
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